Press releases
- Bruker Announces New Two-Year Share Repurchase Authorization of up to $500 Million; Board Declares Quarterly Dividend
- Bruker Announces Acquisition of ZONTAL to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions
- Bruker Reports First Quarter 2023 Financial Results
- Bruker Announces Date and Time of First Quarter 2023 Earnings Release and Webcast
- Bruker Advances NMR Magnet Portfolio, Innovates in Industrial Solutions
- Bruker Introduces New Mycobacteria and Fungi IVD Solutions for MALDI Biotyper®, and a Novel LiquidArray® Gastrointestinal Syndromic Panel
- PreOmics Introduces a Novel BeatBox™ FFPE Workflow for Accelerated, In-depth Tissue Proteomics
- Canopy Biosciences and Enable Medicine Announce Partnership to Bring Advanced Spatial Analysis Pipelines to the ChipCytometry Platform
- Bruker Announces Two 1.2 GHz NMR Systems Orders from the UK
- Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization
More ▼
Key statistics
As of last trade Bruker Corp (BRKR:DEU) traded at 65.50, -14.38% below its 52-week high of 76.50, set on Apr 17, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 65.50 |
---|---|
High | 65.50 |
Low | 65.50 |
Bid | 65.50 |
Offer | 66.00 |
Previous close | 66.50 |
Average volume | 130.09 |
---|---|
Shares outstanding | 146.73m |
Free float | 98.87m |
P/E (TTM) | 33.47 |
Market cap | 10.31bn USD |
EPS (TTM) | 2.10 USD |
Annual div (ADY) | 0.1863 EUR |
---|---|
Annual div yield (ADY) | 0.28% |
Div ex-date | May 31 2023 |
Div pay-date | Jun 16 2023 |
Data delayed at least 15 minutes, as of May 31 2023 07:02 BST.
More ▼